Abstract:Sarcopenia has a high prevalence among the aging population. Sarcopenia is of tremendous socioeconomic importance because it can lead to falls and hospitalization, subsequently increasing healthcare costs while limiting quality of life. In sarcopenic muscle fibers, the E3 ubiquitin ligase F-Box Protein 32 (Fbxo32) is expressed at substantially higher levels, driving ubiquitin-proteasomal muscle protein degradation. As one of the key regulators of muscular equilibrium, the transcription factor Forkhead Box O3 (FOXO3) can increase the expression of Fbxo32, making it a possible target for the regulation of this detrimental pathway. To test this hypothesis, murine C2C12 myoblasts were transduced with AAVs carrying a plasmid for four specific siRNAs against Foxo3. Successfully transduced myoblasts were selected via FACS cell sorting to establish single clone cell lines. Sorted myoblasts were further differentiated into myotubes and stained for myosin heavy chain (MHC) by immunofluorescence. The resulting area was calculated. Myotube contractions were induced by electrical stimulation and quantified. We found an increased Foxo3 expression in satellite cells in human skeletal muscle and an age-related increase in Foxo3 expression in older mice in silico. We established an in vitro AAV-mediated FOXO3 knockdown on protein level. Surprisingly, the myotubes with FOXO3 knockdown displayed a smaller myotube size and a lower number of nuclei per myotube compared to the control myotubes (AAV-transduced with a functionless control plasmid). During differentiation, a lower level of FOXO3 reduced the expression Fbxo32 within the first three days. Moreover, the expression of Myod1 and Myog via ATM and Tp53 was reduced. Functionally, the Foxo3 knockdown myotubes showed a higher contraction duration and time to peak. Early Foxo3 knockdown seems to terminate the initiation of differentiation due to lack of Myod1 expression, and mediates the inhibition of Myog. Subsequently, the myotube size is reduced and the excitability to electrical stimulation is altered.

Sox15 and Fhl3 transcriptionally coactivate Foxk1 and regulate myogenic progenitor cells.

Foxk1 Promotes Cell Proliferation and Represses Myogenic Differentiation by Regulating Foxo4 and Mef2.

Foxk1 Recruits the Sds3 Complex and Represses Gene Expression in Myogenic Progenitors

Fhl2 interacts with Foxk1 and corepresses Foxo4 activity in myogenic progenitors.

Stage-specific Effects of Notch Activation During Skeletal Myogenesis

Foxj3 transcriptionally activates Mef2c and regulates adult skeletal muscle fiber type identity

Forkhead Box M1 Transcriptionally Regulates the Expression of Long Noncoding RNAs Snhg8 and Gm26917 to Promote Proliferation and Survival of Muscle Satellite Cells.

Microrna133a Targets Foxl2 and Promotes Differentiation of C2C12 into Myogenic Progenitor Cells.

The transcriptional regulator KLF15 is necessary for myoblast differentiation and muscle regeneration by activating FKBP5

Sin3 Interacts with Foxk1 and Regulates Myogenic Progenitors

FOXO1 Regulates Bovine Skeletal Muscle Cells Differentiation by Targeting MYH3.

A Cdh1–FoxM1–Apc axis controls muscle development and regeneration

Over-expression of FoxO1 Inhibits the Differentiation of Porcine Skeletal Muscle Myoblast

Skeletal Muscle Satellite Cells Co-Opt the Tenogenic Gene to Instruct Regeneration

Foxo3 Knockdown Mediates Decline of Myod1 and Myog Reducing Myoblast Conversion to Myotubes

Foxc1 Establishes Enhancer Accessibility for Craniofacial Cartilage Differentiation.

Natural Antisense RNA Foxk1-AS Promotes Myogenic Differentiation by Inhibiting Foxk1 Activity

Foxc2 Regulates Osteogenesis and Angiogenesis of Bone Marrow Mesenchymal Stem Cells

Tcf12 is Required to Sustain Myogenic Genes Synergism with MyoD by Remodelling the Chromatin Landscape

Synergistic Effects of TGFβ2, WNT9a, and FGFR4 Signals Attenuate Satellite Cell Differentiation During Skeletal Muscle Development.

SOX9: a stem cell transcriptional regulator of secreted niche signaling factors